Defender Capital, Llc. Arrowhead Pharmaceuticals, Inc. Transaction History

Defender Capital, Llc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$62.15 - $90.32 $248,600 - $361,280	-4,000 Closed	0 $0
Q1 2021 Apr 20, 2021	BUY	$61.35 - $90.47 $245,400 - $361,880	4,000 New	4,000 $270,000
Q4 2020 Jan 25, 2021	SELL	$43.82 - $85.37 $571,851 - $1.11 Million	-13,050 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$33.21 - $51.27 $249,075 - $384,525	7,500 Added 135.14%	13,050 $562,000
Q2 2020 Jul 10, 2020	BUY	$26.12 - $43.27 $144,966 - $240,148	5,550 New	5,550 $240,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Defender Capital, Llc., based on Form 13F filings with the SEC.

Stay updated on Defender Capital, Llc. with notifications on news.